Author:
Bhaskara Achala,Eng Cathy
Subject
Gastroenterology,Oncology
Reference20 articles.
1. Cancer statistics, 2007;Jemal;CA Cancer J Clin,2007
2. Andre T, Tabernero J, Cutsem EV, et al. Phase II study with cetuximab plus FOLFOX4 in first-line setting for epidermal growth factor receptor (EGFR) – expressing metastatic colorectal cancer (mCRC): final results. Presented at: the Gastrointestinal Cancer Symposium; January 19-21, 2007; Orlando, FL. Abstract 334.
3. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma;Schouten;Cancer,2002
4. Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer;Takahashi;Arch Surg,1997
5. Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200;Giantonio;J Clin Oncol,2007
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献